BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35062250)

  • 1. Expansion of CD56
    Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
    Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
    Front Immunol; 2018; 9():2360. PubMed ID: 30374356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between peripheral and decidual NK cell subsets and killer immunoglobulin-like receptors in women with recurrent spontaneous miscarriages.
    El-Badawy O; Helmy AS; Abbas AM; Zahran AM; Afifi NA; Abdel-Rahim MH
    J Reprod Immunol; 2020 Aug; 140():103130. PubMed ID: 32330774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.
    Koo KC; Shim DH; Yang CM; Lee SB; Kim SM; Shin TY; Kim KH; Yoon HG; Rha KH; Lee JM; Hong SJ
    PLoS One; 2013; 8(11):e78049. PubMed ID: 24223759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.
    Harlin H; Hanson M; Johansson CC; Sakurai D; Poschke I; Norell H; Malmberg KJ; Kiessling R
    J Immunol; 2007 Oct; 179(7):4513-9. PubMed ID: 17878347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
    Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
    J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Hope for CD56
    Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
    Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
    Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of human natural killer-cell subsets.
    Cooper MA; Fehniger TA; Caligiuri MA
    Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
    Gomez-Muñoz L; Perna-Barrull D; Villalba A; Rodriguez-Fernandez S; Ampudia RM; Teniente-Serra A; Vazquez F; Murillo M; Perez J; Corripio R; Bel J; Vives-Pi M
    Front Immunol; 2020; 11():611522. PubMed ID: 33569058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.
    Lutz CT; Karapetyan A; Al-Attar A; Shelton BJ; Holt KJ; Tucker JH; Presnell SR
    J Immunol; 2011 Apr; 186(8):4590-8. PubMed ID: 21402893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated KIR expression and diminished intensity of CD7 on NK cell subsets among treatment naïve HIV infected Ethiopians.
    Andualem H; Lemma M; Keflie A; Workeneh M; Ayelign B; Tassachew Y; Hailu L; Geteneh A; Mihret A; Zewdie M; Howe R
    Sci Rep; 2022 Aug; 12(1):14747. PubMed ID: 36042218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection.
    Saresella M; Trabattoni D; Marventano I; Piancone F; La Rosa F; Caronni A; Lax A; Bianchi L; Banfi P; Navarro J; Bolognesi E; Zanzottera M; Guerini FR; Clerici M
    Mol Neurobiol; 2021 Dec; 58(12):6111-6120. PubMed ID: 34453271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.